302 related articles for article (PubMed ID: 27548526)
1. Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.
Mueller SB; Kontos CD
J Clin Invest; 2016 Sep; 126(9):3188-91. PubMed ID: 27548526
[TBL] [Abstract][Full Text] [Related]
2. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
4. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
Song SH; Kim KL; Lee KA; Suh W
Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of angiopoietin-2 and the Tie2 receptor but not angiopoietin-1 or the Tie1 receptor in a rat model of myocardial infarction.
Shyu KG; Liang YJ; Chang H; Wang BW; Leu JG; Kuan P
J Biomed Sci; 2004; 11(2):163-71. PubMed ID: 14966366
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.
Kim M; Allen B; Korhonen EA; Nitschké M; Yang HW; Baluk P; Saharinen P; Alitalo K; Daly C; Thurston G; McDonald DM
J Clin Invest; 2016 Sep; 126(9):3511-25. PubMed ID: 27548529
[TBL] [Abstract][Full Text] [Related]
9. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for angiopoietin-1-mediated signaling initiation.
Yu X; Seegar TC; Dalton AC; Tzvetkova-Robev D; Goldgur Y; Rajashankar KR; Nikolov DB; Barton WA
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7205-10. PubMed ID: 23592718
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap.
Bate N; Lodge J; Brindle NPJ
J Biol Chem; 2021 Aug; 297(2):100888. PubMed ID: 34153320
[TBL] [Abstract][Full Text] [Related]
12. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
13. The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFα and regulates angiopoietin signalling.
Singh H; Hansen TM; Patel N; Brindle NP
PLoS One; 2012; 7(1):e29319. PubMed ID: 22235284
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of angiopoietin-2 and Tie2 receptor in a rat model of myocardial ischaemia/reperfusion.
Shyu KG; Chang CC; Wang BW; Kuan P; Chang H
Clin Sci (Lond); 2003 Sep; 105(3):287-94. PubMed ID: 12737621
[TBL] [Abstract][Full Text] [Related]
15. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
Yuan HT; Venkatesha S; Chan B; Deutsch U; Mammoto T; Sukhatme VP; Woolf AS; Karumanchi SA
FASEB J; 2007 Oct; 21(12):3171-83. PubMed ID: 17504972
[TBL] [Abstract][Full Text] [Related]
16. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.
Akwii RG; Sajib MS; Zahra FT; Mikelis CM
Cells; 2019 May; 8(5):. PubMed ID: 31108880
[TBL] [Abstract][Full Text] [Related]
17. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
18. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
[TBL] [Abstract][Full Text] [Related]
19. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]